Author

Elin Stemme

Lund UniversityORCID 0009-0007-0278-6229Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander J. DeariD· 2 shared Dev ThackeriD· 2 shared Sara Snogerup LinseiD· 2 shared Tuomas P. J. KnowlesiD· 2 shared Anđela ŠarićiD· 1 shared Emil AxelliD· 1 shared Emma SparriD· 1 shared Ewa A. AndrzejewskaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Alexander J. DearORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintJul 31, 2026

Errors in peptide synthesis are a source of discrepancies in Aβ42 studies

Karolina Matulewska-Sobczuk, Katja Bernfur, Dev Thacker…·Lei Ortigosa-Pascual

This study shows that sequence imperfections in synthetic Aβ42 peptides cause differences in aggregation behavior compared to recombinant Aβ42.

DOI 10.64898/2026.07.30.741826

proteomicsexperimental assay

𝕏 PostBluesky

BiophysicsNature CommunicationsPeer-reviewedFeb 18, 2026

Structural defects in amyloid-β fibrils drive secondary nucleation

Jing Hu, Tom Scheidt, Dev Thacker…·Alexander J. Dear

This study shows that structural defects in amyloid-β fibrils are key sites for secondary nucleation, suggesting new strategies for drug design to inhibit amyloid disorders.

7 citationstop 1%

humanprotein structure

𝕏 PostBluesky